STAT3: A Molecular Target for Cancer Whose Time Has Come
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
239-253
Author(s):
Beverly E. Barton
n-3 Polyunsaturated Fatty Acids as Signal Transduction Modulators and Therapeutical Agents in Cancer
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
255-271
Author(s):
Gabriella Calviello, Simona Serini and Paola Palozza
Emerging Role of Stromal Fibroblasts in Epithelial Cancer
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
273-283
Author(s):
Maria Rita Rippo, Antonio Procopio and Alfonso Catalano
Carotenoids as Modulators of Intracellular Signaling Pathways
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
325-335
Author(s):
Paola Palozza, Simona Serini and Gabriella Calviello
The ‘Arimidex’, Tamoxifen, Alone or in Combination (ATAC) Trial: A Step Forward in the Treatment of Early Breast Cancer
Journal:
Reviews on Recent Clinical Trials
Volume:
1
Page:
207-215
Author(s):
Anthony Howell
The Emerging Role of Aromatase Inhibitors in the Adjuvant Management of Breast Cancer
Journal:
Reviews on Recent Clinical Trials
Volume:
1
Page:
237-249
Author(s):
Jean Marc Nabholtz and Joseph Gligorov
Current Status of Clinical Trials for Glioblastoma
Journal:
Reviews on Recent Clinical Trials
Volume:
1
Page:
265-281
Author(s):
Michael L. Salgaller and Linda M. Liau
Specific Active Immunotherapy of Cancer: Potential and Perspectives
Journal:
Reviews on Recent Clinical Trials
Volume:
1
Page:
283-292
Author(s):
Roopa Srinivasan and Dennis E. Van Epps
Biomarkers and Multiple Drug Resistance in Breast Cancer
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
365-384
Author(s):
L. O'Driscoll and M. Clynes
Reversal of Resistance to Oxazaphosphorines
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
385-407
Author(s):
Jing Zhang, Quan Tian, Yi-Zhun Zhu, An-Long Xu and Shu-Feng Zhou